[1]EuropeanJournalofOrganicChemistry,2011,p.1429-1431
Title: Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.
Journal: British journal of pharmacology 20120301
1142-39-8
115595-30-7
124389-14-6
126521-53-7
137407-31-9
15872-42-1
13382-86-0 | Manninotriose | AA009BGT | MFCD30478852
121578-11-8 | N-NONANE-D20 | AA009BIJ | MFCD00209767
1334499-91-0 | 1-(2,4-Difluorophenyl)pyrrolidine | AA009BPL | MFCD20231457
132685-02-0 | PEAK E | AA009BYF | MFCD09842569
1372540-25-4 | GSK2636771 | AA009C9B | MFCD22417098
1346599-45-8 | Azilsartan-d5 | AA009CE7 | MFCD28900706
1426802-50-7 | N-(2,6-dichloro-2'-(trifluoromethoxy)-[1,1'-biphenyl]-4-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide | AA009CHB | MFCD28902182
1361110-64-6 | 3,4-Dihydro-2H-1,4-benzoxazine-7-boronic acid pinacol ester | AA009CPB | MFCD24038761
1216413-74-9 | NORVERAPAMIL-D6, HYDROCHLORIDE | AA009D4C | MFCD09264525
133852-23-0 | Fmoc-Tyr-OtBu | AA009DEI | MFCD20264831